Propanc Biopharma released FY2024 Q2 earnings on February 20, 2024 (EST) with actual revenue of USD 0 and EPS of USD 0

Brief Summary

In its second-quarter fiscal year 2024 financial results, Propanc Biopharma reported $0 in revenue, a net loss of $618,969, and an earnings per share of $0 .

Impact of The News

Analysis of Propanc Biopharma’s Q2 FY2024 Financial Report